Standout Papers
Citation Impact
Citing Papers
Etanercept plus Standard Therapy for Wegener's Granulomatosis
2005
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Effective treatment of severe COVID-19 patients with tocilizumab
2020 Standout
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Incidence of giant cell arteritis in Western Norway 1972–2012: a retrospective cohort study
2017
Racial and ethnic disparities in utilization of total knee arthroplasty among older women
2019
Thrombosis in vasculitis: from pathogenesis to treatment
2015
The Triple Aim: Care, Health, And Cost
2008 Standout
EULAR recommendations for the management of primary small and medium vessel vasculitis
2008 Standout
Treatment of Refractory Churg-Strauss-Syndrome (CSS) by TNF- Blockade
2002
Leishmaniasis
2018 Standout
Inflammation and cancer
2002 StandoutNature
Successful Treatment of Childhood Onset Refractory Polyarteritis Nodosa With Tumor Necrosis Factor Alpha Blockade
2005
A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies
2003 Standout
Acute kidney injury
2012 Standout
Myasthenia Gravis
2016 Standout
Targeting Interleukin-6 Signaling in Clinic
2019
cGAS produces a 2′-5′-linked cyclic dinucleotide second messenger that activates STING
2013 StandoutNature
Sjögren's syndrome
2005 Standout
The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes
2013
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Tocilizumab – A novel therapy for non-organ-specific autoimmune diseases
2012
Treatment of Pulmonary Arterial Hypertension
2004 Standout
Prospective Study of TNFα Blockade with Infliximab in Anti-Neutrophil Cytoplasmic Antibody-Associated Systemic Vasculitis
2004
Pathogenesis and therapy of psoriasis
2007 StandoutNature
Randomised, double blind, placebo-controlled trial of selenium supplementation in adult asthma
2007
Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005
2005
Biologic agents in rheumatology: unmet issues after 200 trials and $200 billion sales
2013
Immune mechanisms in medium and large-vessel vasculitis
2013
Pancreatic cancer
2016 Standout
Levels of sP-selectin and hs-CRP Decrease with Dietary Intervention with Selenium and Coenzyme Q10 Combined: A Secondary Analysis of a Randomized Clinical Trial
2015 StandoutNobel
Down-regulation of CD40 and CD80 on B cells in patients with life-threatening systemic lupus erythematosus after successful treatment with rituximab
2004
Psoriasis
2021 Standout
Selenium and human health
2012 Standout
Tumor Necrosis Factor-α Blockade: A Novel Therapy for Rheumatic Disease
2002
Medium- and Large-Vessel Vasculitis
2003
Mucocutaneous leishmaniasis must be included in the differential diagnosis of midline destructive disease: two case reports
2014
Osteoarthritis
2015 Standout
Treatment for Rheumatoid Arthritis and Risk of Alzheimer’s Disease: A Nested Case-Control Analysis
2016
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Graves' Ophthalmopathy
2010 Standout
Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2
2004
Gout
2016 Standout
Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial
2016
Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: Results of a multicenter, prospective, open‐label study of twenty‐two patients
2007
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing
2015
Enhanced Activation of Memory, but Not Naïve, B Cells in Chronic Hepatitis C Virus-Infected Patients with Cryoglobulinemia and Advanced Liver Fibrosis
2013 StandoutNobel
Solid malignancies among patients in the Wegener's granulomatosis etanercept trial
2006
Severe Adverse Cutaneous Reactions to Drugs
1994 Standout
Use of tumor necrosis factor-α (TNF-α) antagonists infliximab, etanercept, and adalimumab in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective record review of 11 patients
2009
Prevalence of infective endocarditis in patients with Staphylococcus aureus bacteraemia: the value of screening with echocardiography
2011
Psoriasis
2003
Prevalence of connective tissue disease in silicosis (1985–2006)—a report from the state of michigan surveillance system for silicosis
2010
Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty‐year period
2004
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part II
2007 Standout
ANCA Disease
2010
Risks of immunosuppressive therapies including biologic agents in patients with rheumatic diseases and co-existing chronic viral infections
2007
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
2015 Standout
Safety of Tumour Necrosis Factor-?? Antagonists
2004
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
2010 Standout
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
2013 Standout
Herpes Zoster Risk Factors in a National Cohort of Veterans with Rheumatoid Arthritis
2009
Herpes Zoster
2013 Standout
Cutaneous Vasculitis in Primary Sjögren Syndrome
2004
Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort
2015
Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies
2006 Standout
Complete recovery from refractory immune thrombocytopenic purpura in three patients treated with etanercept
2003
IgG Subclasses and Allotypes: From Structure to Effector Functions
2014 Standout
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons
2017 StandoutNobel
New Drugs for Rheumatoid Arthritis
2004
Silicosis
2012 Standout
Interleukin-6 Signaling, Soluble Glycoprotein 130, and Inflammation in Heart Failure
2014
Rituximab for Refractory Wegener's Granulomatosis
2005
The Role of Selenium in Inflammation and Immunity: From Molecular Mechanisms to Therapeutic Opportunities
2011 Standout
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Antibody-Mediated Encephalitis
2018 Standout
Activation of Arterial Wall Dendritic Cells and Breakdown of Self-tolerance in Giant Cell Arteritis
2004
Chronic Kidney Disease Diagnosis and Management
2019 Standout
Giant-Cell Arteritis and Polymyalgia Rheumatica
2003
DPPX antibody–associated encephalitis
2017
The association between hydroxychloroquine treatment and cardiovascular morbidity among rheumatoid arthritis patients
2017
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Diagnosis and Treatment of Hip and Knee Osteoarthritis
2021 Standout
Giant Cell Arteritis versus Takayasu Arteritis: An Update
2020
Global Disparities of Hypertension Prevalence and Control
2016 Standout
Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves
2009 StandoutNobel
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Cytokine Storm
2020 Standout
Knee osteoarthritis has doubled in prevalence since the mid-20th century
2017 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).
2008 Standout
Phenytoin hypersensitivity reaction presenting with toxic epidermal necrolysis and severe hepatitis
1985
Immune control and failure in HCV infection—tipping the balance
2014
STING manifests self DNA-dependent inflammatory disease
2012
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Works of John H. Stone being referenced
Limited versus severe Wegener's granulomatosis: Baseline data on patients in the Wegener's granulomatosis etanercept trial
2003
Tocilizumab for the treatment of large‐vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica
2012
Trial of Tocilizumab in Giant-Cell Arteritis
2017 Standout
Inpatient complications in patients with giant cell arteritis: decreased mortality and increased risk of thromboembolism, delirium and adrenal insufficiency
2015
Newly diagnosed vs. relapsing giant cell arteritis: Baseline data from the GiACTA trial
2016
IgG4-Related Disease
2012 Standout
Communication between Physicians and Patients in the Era of E-Medicine
2007
Chronic Sclerosing Sialadenitis (Küttner Tumor) Is an IgG4-associated Disease
2010
The cryoglobulinaemias
2011
Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4‐related systemic disease
2010
Management of systemic sclerosis: The art and science
1998
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I
2007 Standout
Temporal arteritis and Chlamydia pneumoniae: Failure to detect the organism by polymerase chain reaction in ninety cases and ninety controls
2002
A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis
2011
IgG4-Related Disease and Hypertrophic Pachymeningitis
2013
Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis
2008
IgG4-related disease
2014 Standout
Etanercept combined with conventional treatment in Wegener's granulomatosis: A six-month open-label trial to evaluate safety
2001
Herpes zoster in immunocompromised patients: Incidence, timing, and risk factors
2005
Antiproteinase 3 Antineutrophil Cytoplasmic Antibodies and Disease Activity in Wegener Granulomatosis
2007
ANCA Are Detectable in Nearly All Patients with Active Severe Wegener’s Granulomatosis
2007
“Essential” cutaneous vasculitis: what every rheumatologist should know about vasculitis of the skin
2001
Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial.
2007
IgG4-Related Disease
2013 Standout
Reply
2003
Current status of outcome measures in vasculitis: focus on Wegener's granulomatosis and microscopic polyangiitis. Report from OMERACT 7.
2005
Etanercept combined with conventional treatment in Wegener's granulomatosis: A six‐month open‐label trial to evaluate safety
2001
New approaches to treatment in systemic vasculitis: biological therapies
2001
IgG4-Related Disease
2013
The frequency of anticardiolipin antibodies and genetic mutations associated with hypercoagulability among patients with Wegener's granulomatosis with and without history of a thrombotic event.
2007
Treatment of non-life threatening Wegener's granulomatosis with methotrexate and daily prednisone as the initial therapy of choice.
1999
Exanthem due to diphenylhydantoin therapy.
1970
Reduced Selenium Status of Patients with Asthma
1989